Christopher M. Heaphy, Ph.D.
Affiliations: | 2008 | University of New Mexico, Albuquerque, NM, United States |
Area:
Genetics, OncologyGoogle:
"Christopher Heaphy"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Jeffrey Griffith | grad student | 2008 | Univ. of New Mexico | |
| (Evaluation of genomic instability as an early event in the progression of breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mori JO, Elhussin I, Brennen WN, et al. (2023) Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer. Nature Reviews. Urology |
| Mori JO, Keegan J, Flynn RL, et al. (2023) Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer. Journal of Clinical Pathology |
| Ertunc O, Smearman E, Zheng Q, et al. (2023) Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate. Biorxiv : the Preprint Server For Biology |
| Jafari N, Chen A, Kolla M, et al. (2022) Novel plasma exosome biomarkers for prostate cancer progression in co-morbid metabolic disease. Advances in Cancer Biology - Metastasis. 6 |
| Low JY, Ko M, Hanratty B, et al. (2022) Genomic Characterization of Prostatic Basal Cell Carcinoma. The American Journal of Pathology |
| Heaphy CM, Joshu CE, Barber JR, et al. (2022) The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy. The Journal of Pathology. Clinical Research |
| Shrestha E, Coulter JB, Guzman W, et al. (2021) Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Hempel Sullivan H, Maynard JP, Heaphy CM, et al. (2020) Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes. The Journal of Pathology |
| Heaphy CM, Bi WL, Coy S, et al. (2020) Telomere length alterations and ATRX/DAXX loss in pituitary adenomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc |
| Hempel Sullivan H, Heaphy CM, Kulac I, et al. (2020) High Extra-tumoral Mast Cell Counts are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology |